Jennifer L Hellawell MD

Director, Early Development Cardiometabolic, Amgen

850 Harrison Ave# YaccBoston, MA 02118
Phone+1 617-414-2080
Fax+1 617-414-2090

Dr. Hellawell is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hellawell's full profile Already have an account?

Education & Training

Stanford Health CareFellowship, Pulmonary Vascular Diseases, 2014 - 2015
Boston University Medical CenterFellowship, Cardiovascular Disease, 2011 - 2014
University of Pennsylvania Health SystemResidency, Internal Medicine, 2008 - 2011
Weill Cornell MedicineClass of 2008

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2014 - 2028
MA State Medical License 2012 - 2016
PA State Medical License 2008 - 2014
American Board of Internal Medicine Internal Medicine
National Board of EchocardiographyLevel 3 Testamur

Clinical Trials

Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10 Start of enrollment: 2017 Sep 11
COMPLETED
PHASE1

Publications & Presentations

PubMed

10 citations
Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and Number in Hypertriglyceridemia.
Christie M Ballantyne, Daniel Gaudet, Robert S Rosenson, Robert A Hegele, Rong Zhou
Journal of the American College of Cardiology. 2025-05-20
2 citations
Temporal Effects of Plozasiran on Lipids and Lipoproteins in Persistent Chylomicronemia.
Gerald F Watts, Robert A Hegele, Robert S Rosenson, Ira J Goldberg, Antonio Gallo
Circulation. 2025-03-11
103 citations
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.
Gerald F Watts, Robert S Rosenson, Robert A Hegele, Ira J Goldberg, Antonio Gallo
The New England Journal of Medicine. 2025-01-09